The chemical class of LOC100040458 Inhibitors, also known as Btbd35f26 inhibitors, comprises a unique set of compounds specifically formulated to target and inhibit the activity of the LOC100040458 gene product, referred to as Btbd35f26. This gene, identified through comprehensive genomic research, holds a crucial role in a variety of cellular processes. The function of LOC100040458, or Btbd35f26, is known to be context-dependent, varying significantly with the cellular environment and external stimuli. The inhibitors in this class are designed to bind selectively to the proteins or enzymes that are expressed as a result of the activation of this gene. This binding mechanism is central to the function of these inhibitors, as it directly interferes with the biological pathways in which the Btbd35f26 gene product is involved. Through this targeted interaction, the inhibitors aim to modulate the activity of the Btbd35f26 gene product, thereby influencing the corresponding cellular functions.
The development of LOC100040458 or Btbd35f26 Inhibitors is a complex and interdisciplinary endeavor, drawing on expertise from molecular biology, chemistry, and structural biology. To design these inhibitors effectively, a thorough understanding of the structure and function of the Btbd35f26 gene product is essential. Advanced methodologies such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are employed to gain intricate insights into the target molecule. This in-depth knowledge enables the rational design of inhibitors that are both highly effective in their interaction and remarkably specific to their target. Typically, these inhibitors are small molecules, optimized to penetrate cellular membranes efficiently and to engage in a stable and robust interaction with their target. The molecular architecture of these inhibitors is carefully crafted to ensure the formation of strong hydrogen bonds, hydrophobic interactions, and van der Waals forces with the target molecule. The efficacy of these inhibitors is rigorously tested through various in vitro biochemical assays. These assays are critical in assessing the inhibitors' potency, specificity, and the general behavior in controlled experimental conditions. Such studies provide invaluable data on the inhibitors' mechanism of action and interaction dynamics, forming a solid foundation for further exploration and understanding of their role in influencing cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
An analog of cytidine that can be incorporated into DNA and RNA. It inhibits DNA methyltransferases, potentially leading to reduced gene expression due to hypomethylation of DNA. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase (HDAC) inhibitor. By increasing histone acetylation, it may lead to a more open chromatin structure and altered gene expression patterns. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A non-nucleoside DNA methyltransferase inhibitor. It may prevent DNA methylation, which could result in the activation of silenced genes and indirect inhibition of gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Another nucleoside analog that inhibits DNA methyltransferases, potentially leading to the reactivation of silenced genes and indirect changes in gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
An HDAC inhibitor that can alter chromatin structure and affect gene expression by increasing histone acetylation levels. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
A PARP inhibitor that, by inhibiting PARP enzymes, may indirectly influence gene expression patterns linked to DNA repair and chromatin remodeling. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
A compound that binds to GC-rich sequences in DNA, potentially affecting the expression of certain genes by blocking binding sites for transcription factors. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
An HDAC inhibitor that may alter gene expression by changing the acetylation status of histones associated with specific genes. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
An inhibitor of aldehyde dehydrogenase that can modulate various cellular pathways, potentially leading to indirect changes in gene expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
A small molecule that inhibits BET bromodomain proteins, potentially affecting gene expression by altering the reading of acetylation marks on histones. | ||||||